Archemix

Aptamer therapeutics for rare hematological diseases

placeSan Francisco, California, United States calendar_todayFounded 2000 groups79 employees language archemix.com

Registered entities

Innovation

62 patent families (28 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 8,104 times.

YearFilings
201210
20138
20149
20155
201612
20175
20184
20193
20202
20213
20221
20231

Investor mix

12 investors on record; lead investors include Highland Capital Partners, Atlas Venture, Prospect Venture Partners, SV Health Investors.

Investor typeCountShare
Venture capital1192%
Other / undisclosed18%
Coming soon